Search Results - bevacizumab antibody

Palivizumab Biosimilar, Anti-RSV Antibody C021P Syd Labs

Palivizumab Biosimilar, Anti-RSV Antibody | C021P

Palivizumab Biosimilar, RSV Monoclonal Antibody. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...

Panitumumab Biosimilar, Anti-human EGFR Monoclonal Antibody C012P Syd Labs

Panitumumab Biosimilar, Anti-human EGFR Antibody | C012P

Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant...

Trastuzumab Biosimilar, N297A Mutant Syd Labs

Trastuzumab Biosimilar, N297A Mutant | C009P.NA

Trastuzumab Biosimilar, N297A Mutant. The research grade trastuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Trastuzumab biosimilar (clone huMAb 4D5-8) is the humanized anti-human HER2 mouse monoclonal...

Rituximab Biosimilar, Mouse IgG1 C010P.m1 Syd Labs

Rituximab Biosimilar, Mouse IgG1 | C010P.m1

Rituximab Biosimilar, Mouse IgG1. The research grade rituximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Rituximab biosimilar CHO stable cell line is available for licensing to manufacture...

Rituximab Biosimilar, Mouse IgG2 C010P.m2a Syd Labs

Rituximab Biosimilar, Mouse IgG2 | C010P.m2a

Rituximab Biosimilar, Mouse IgG2a. The research grade rituximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Rituximab biosimilar CHO stable cell line is available for licensing to manufacture...

Rituximab Biosimilar, N297A Mutant C010P.NA Syd Labs

Rituximab Biosimilar, N297A Mutant | C010P.NA

Rituximab Biosimilar, N297A Mutant. The research grade rituximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Rituximab biosimilar CHO stable cell line is available for licensing to manufacture...